Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Parenthetical) (Details) - shares |
Sep. 30, 2020 |
Feb. 12, 2020 |
Dec. 31, 2019 |
Nov. 30, 2019 |
Sep. 30, 2019 |
---|---|---|---|---|---|
Anti-dilutive securities | |||||
Warrant issued to purchase common stock | 2,118,094 | 2,118,344 | |||
Preferred stock, shares outstanding | 0 | 0 | |||
Convertible Preferred Stock | |||||
Anti-dilutive securities | |||||
Preferred stock, shares outstanding | 0 | 666 | |||
Convertible Preferred Stock | Common Stock | |||||
Anti-dilutive securities | |||||
Conversion preferred stock into common stock | 666,000 | ||||
Loan Agreement | |||||
Anti-dilutive securities | |||||
Warrant issued to purchase common stock | 27,548 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares issued for each share of convertible preferred stock that is converted. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|